Abstract
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes
Highlights
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes
Concern about high out-of-pocket spending for insulin has prompted states, payers, and pharmacy benefit managers to limit cost-sharing in the US.[1,2]
The database included patients who received insurance from medium to large firms,[3] which typically offer plans with lower deductibles compared with plans offered by small firms.[6]
Summary
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes Concern about high out-of-pocket spending for insulin has prompted states, payers, and pharmacy benefit managers to limit cost-sharing in the US.[1,2] In addition to insulin, patients with type 1 diabetes might have out-of-pocket expenses for other care, such as diabetes-related supplies. Using national 2018 claims data, we estimated out-of-pocket spending for insulin and other health care services for privately insured patients with type 1 diabetes.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
